• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    SARS-CoV-2 R&D: Is It Over?

    Sustainability: A New Threat or Opportunity for CDMOs?

    Advanced Therapy Manufacturing

    Advanced Therapy Packaging Trends

    CEO Spotlight: Darren Head
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Mirum Pharmaceuticals Acquires San Diego-based Satiogen

    Catalyst Biosciences Sells Complement Portfolio to Vertex Pharmaceuticals

    Insmed Appoints Drayton Wise as Chief Commercial Officer

    Clinigen Expands U.S. Site Capacity

    Corealis CDMO Completes Deal with ArchiMed
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Risk Assessment for a Nitrosamine Contamination of Peptide APIs Manufactured by SPPS

    Clinigen Expands U.S. Site Capacity

    Corealis CDMO Completes Deal with ArchiMed

    Piramal Pharma Solutions Upgrades Oral Solid Dose Capabilities

    Lonza, IBF Partner on Drug Development, Manufacture for Portfolio Cos
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Selecting a CMO Partner for Sterile Injectable Manufacturing

    Royalty Pharma and Jefferies Invest $111M in ApiJect

    Cryoport Acquires Cell&Co BioServices for €6.2M

    Challenges of Developing Large Volume Drug/Device Combination Products for Parenteral SC Delivery

    Yourway Adds Capacity for Controlled Ambient Storage
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    How Can Automation Optimize Immunohistochemistry?

    Corealis CDMO Completes Deal with ArchiMed

    Lonza, IBF Partner on Drug Development, Manufacture for Portfolio Cos

    Aptamer Group and PinotBio Extend Collaboration Agreement

    Selecting a CMO Partner for Sterile Injectable Manufacturing
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    FDA Inspection Trends Update

    Phase-Appropriate cGMP Considerations for Cell and Gene Therapy

    Sustainability: A New Threat or Opportunity for CDMOs?

    In Pursuit of Sustainability: How the Biopharma Industry Can Contribute

    Conducting Clinical Trials During the Pandemic: What Did We Learn?
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Qosina

    Quotient Sciences

    Aphena Pharma Solutions

    Alcami

    Biosynth Carbosynth
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Qosina

    Quotient Sciences

    Aphena Pharma Solutions

    Alcami

    Biosynth Carbosynth
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Expert's Opinion

    Innovative Manufacturing Technology for Aseptic Filling

    V-CRT: Combining quality and OEE advantages

    Innovative Manufacturing Technology for Aseptic Filling
    Vetter filling line in a restricted access barrier system (RABS).
    Innovative Manufacturing Technology for Aseptic Filling
    Simplified representation of the zones in the V-CRT.
    Related CONTENT
    • Pii Names Head of Aseptic Operations
    • TurboFil Introduces Benchtop Syringe Filler
    • SP Doubles Manufacturing Capacity for Fill-Finish and Freeze Dryers
    • Aenova Expands Capacity for Fill & Finish of Vaccines and Biologics
    • Vetter - Your Partner in Aseptic Filling and Packaging
    Gerald Buerkle, Vice President Production, Vetter Pharma-Fertigung GmbH & Co. KG04.20.17
    Vetter cleanroom technology (V-CRT) is a new and safe manufacturing technology developed for the aseptic filling of injection systems, combining the advantages of an isolator’s excellent sterility with the flexible and economical production processes of restricted access barrier systems (RABS). This innovative approach is based on the central idea of a fully automated decontamination of the cleanroom, including the RABS, using hydrogen peroxide (H2O2). Due to this novel approach, the downtime in production is minimized to three hours. Greater efficiency translates as increased overall equipment effectiveness (OEE) on the filling lines.

    Requirements of pharmaceutical service providers in aseptic filling
    Contract manufacturers in the worldwide pharmaceutical industry must answer to regulatory agencies. However, each market has its own specific demands. In addition, drug manufacturers are increasingly seeking solutions designed to meet their specific needs. The challenge is that pharmaceutical contract manufacturers must be able to offer reliable processes for aseptic filling while also supporting pharmaceutical companies with manufacturing technologies that are both economical and effective.

    Until recently, two different technologies were primarily used to perform high-quality aseptic filling of drugs—isolators and RABS. Simply put, isolators are considered the best solution in achieving the highest levels of sterility, unlike RABS, which allows companies to switch products on a line rapidly. RABS is considered the more flexible solution, achieving comparative levels of sterility.

    The function of V-CRT
    Forecasts suggest that in the future, international regulatory agencies will be demanding limit values when approving drugs. Most likely, microbiological contaminations will be entirely proscribed. Companies that work with isolators will generally be able to meet the new requirements. However, to ensure safe processes, isolators must be thoroughly decontaminated and reset at each product. These format change result in fairly long downtimes. Because manufacturing plants will have to produce quickly and flexibly, decontamination and set-up processes will require greater attention in years to come.

    RABS: High quality and flexibility
    The technical structure of the V-CRT is based on the passive, open RABS idea, one that has proven its worth. While there is no dedicated ventilation technology, RABS are driven by cleanroom ventilation. Because RABS plants have to be integrated into a higher cleanroom class, the protective housing around the production section is not as clearly separated from the environment as isolators.

    Due to automatic decontamination, the level of sterility in isolators is greater than in conventional RABS plants with manual disinfection. However, they are not as flexible. And, it is that high level of flexibility of RABS that delivers the benefit of short downtimes. The challenge, therefore, is to do a filling that is both flexible and safe. One possible solution is an approach that combines the two technologies.

    Flexible and sterile with H2O2 decontamination
    The originality of V-CRT is that it performs a full decontamination of the cleanroom, including the RABS, by using H2O2. This can be done after each batch. In contrast to wipe and spray disinfection, this hydrogen peroxide method has a greater effect on contamination. For example, the system is better at preventing bacterial load than the isolator because prep work is done behind closed barriers in an aseptic environment.

    V-CRT reduces the time it takes for the decontaminants to take effect and, consequently, shortens the down time of the filling line. The net result is a much shorter decontamination time for the cleanroom area of RABS plants.

    V-CRT is a closed, fully automated dispersion system that is integrated into cleanroom technology. The H2O2 is not funneled into the cleanroom via the climate control system. Furthermore, most of it is evacuated by way of a separate ventilation system. A system of stainless steel tubes built into the cleanroom walls vaporizes the H2O2 solution into a class ISO 5 and 7 cleanroom through dual-substance jets embedded in the ceiling and walls. The process takes only three hours, incredibly fast by today's standards, and can immediately be followed by preparations for production and the aseptic setup of the cleanroom.

    Quality and OEE
    V-CRT achieves safety and quality standards that go beyond current good manufacturing practice (cGMP) and as such, is able to compete with the performance of isolators. The shorter down times not only make processes more efficient, but also improve OEE by as much as 30% in comparison to isolator technology. The special conditions required for implementing RABS lines and the fully automated decontamination process are the reason why OEE is optimized. Overall, this cleanroom technology can reduce the time for preparatory production measures and its follow-up steps by nearly half.

    Challenges in the future
    The challenges for the future will essentially involve three aspects of the V-CRT: duration of decontamination; measurement of the remaining H2O2 concentration; and the aseptic transfer of sterilized materials.

    The primary goal was to reduce the decontamination process to less than four hours. This was achieved by using active charcoal filters that have a catalytic effect on the destruction of H2O2.

    A second goal is to measure the remaining concentration of H2O2 online during a batch. Absorption and desorption studies will provide information about materials in the cleanrooms that absorb or dispense H2O2 that could have a negative impact on certain materials. Transferring sterilized materials is done using a conventional docking system based on today’s options for the transfer of all presterilized systems.

    Innovative technology for aseptic filling
    The new manufacturing technology improves quality and safety in systems performing aseptic filling of injection systems. At the same time, it optimizes production processes by making them more flexible and efficient. Put another way, the technology combines advantages of conventional processes—isolators and RABS—and turns them into a new process in aseptic filling. V-CRT meets tomorrow’s official regulations today, and the economic challenges as well.


    Gerald Buerkle is vice president of production at Vetter Pharma-Fertigung GmbH & Co. KG in Ravensburg, Germany. He began his career at Vetter in 2002 as head of production and was initially in charge of five manufacturing lines for customer fillings. In 2005, he was named site manager and manufacturing manager at the site Ravensburg Vetter South. Mr. Buerkle has over 18 years’ experience in the pharmaceutical industry.
    Related Searches
    • quality
    • Filling
    • Sterile
    • it
    Suggested For You
    Pii Names Head of Aseptic Operations Pii Names Head of Aseptic Operations
    TurboFil Introduces Benchtop Syringe Filler TurboFil Introduces Benchtop Syringe Filler
    SP Doubles Manufacturing Capacity for Fill-Finish and Freeze Dryers SP Doubles Manufacturing Capacity for Fill-Finish and Freeze Dryers
    Aenova Expands Capacity for Fill & Finish of Vaccines and Biologics Aenova Expands Capacity for Fill & Finish of Vaccines and Biologics
    Vetter - Your Partner in Aseptic Filling and Packaging Vetter - Your Partner in Aseptic Filling and Packaging
    Aenova Expands Sterile Production Capacity Aenova Expands Sterile Production Capacity
    Evonik Strengthens Partnership with BioNTech on COVID-19 Vaccine Evonik Strengthens Partnership with BioNTech on COVID-19 Vaccine
    Cytiva Acquires Canadian Aseptic Filling Innovator Cytiva Acquires Canadian Aseptic Filling Innovator
    Cytiva Acquires Vanrx Pharmasystems Cytiva Acquires Vanrx Pharmasystems
    LSNE Expands Fill Finish and Lyophilization Ops LSNE Expands Fill Finish and Lyophilization Ops
    Injectables Firms Expand Capacity Injectables Firms Expand Capacity
    CDMO QCL Expands Fill Finish Capabilities CDMO QCL Expands Fill Finish Capabilities
    A Holistic Cleanroom Concept: Higher Quality and Greater Flexibility A Holistic Cleanroom Concept: Higher Quality and Greater Flexibility
    Vetio Animal Health Vetio Animal Health
    Vetter, Microdermics Enter Strategic Drug Delivery Alliance Vetter, Microdermics Enter Strategic Drug Delivery Alliance

    Related Content

    • Aseptic Processing | Breaking News | cGMP Manufacture | Promotions & Moves
      Pii Names Head of Aseptic Operations

      Pii Names Head of Aseptic Operations

      Roberto Almodóvar Febles will oversee and manage day-to-day aseptic manufacturing.
      08.31.21

    • Fill/Finish | Reader Showcase
      TurboFil Introduces Benchtop Syringe Filler

      TurboFil Introduces Benchtop Syringe Filler

      Designed to offer full control of filling parameters in single or dual operation and provide accurate, consistent fills at a rate of up to 12 pieces per minute.
      07.23.21

    • Aseptic Processing | Breaking News | Facilities | Fill/Finish | Industry News
      SP Doubles Manufacturing Capacity for Fill-Finish and Freeze Dryers

      SP Doubles Manufacturing Capacity for Fill-Finish and Freeze Dryers

      New plant opened for SP i-Dositecno aseptic filling lines equipment and global workforce increased to grow capacity and capabilities.
      07.12.21


    • Breaking News | Facilities | Fill/Finish | Industry News | Parenterals | Vials
      Aenova Expands Capacity for Fill & Finish of Vaccines and Biologics

      Aenova Expands Capacity for Fill & Finish of Vaccines and Biologics

      New €16M area for sterile production including vaccine fill and finish is being built at the Aenova site in Latina, Italy.
      Tim Wright, Editor, Contract Pharma 05.07.21

    • Vetter - Your Partner in Aseptic Filling and Packaging

      Watch this video to learn how we support companies worldwide from development through to market launch and beyond.

      Trending
      • How Can Automation Optimize Immunohistochemistry? | Contract Pharma
      • Catalyst Biosciences Sells Complement Portfolio To Vertex Pharmaceuticals | Contract Pharma
      • Corealis CDMO Completes Deal With ArchiMed | Contract Pharma
      • Mirum Pharmaceuticals Acquires San Diego-based Satiogen | Contract Pharma
      • Lonza Invests In Additional Inhalation Capabilities In Tampa | Contract Pharma
      Breaking News
      • Mirum Pharmaceuticals Acquires San Diego-based Satiogen
      • Catalyst Biosciences Sells Complement Portfolio to Vertex Pharmaceuticals
      • Insmed Appoints Drayton Wise as Chief Commercial Officer
      • Clinigen Expands U.S. Site Capacity
      • Corealis CDMO Completes Deal with ArchiMed
      View Breaking News >
      CURRENT ISSUE

      May 2022

      • Sustainability and the Biopharma Industry
      • Contract Manufacturing During COVID
      • Orphan Drugs in the United States
      • CEO Spotlight: Peter DeYoung
      • CEO Spotlight: Darren Head
      • Advanced Therapy Packaging Trends
      • Advanced Therapy Manufacturing
      • Sustainability: A New Threat or Opportunity for CDMOs?
      • SARS-CoV-2 R&D

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      Thorne Relaunches Gut Health Test with Microbiome Wipe
      Alkemist Labs Announces Alkemist Assured Seal and Next Generation Transparency Reports
      GC Rieber Foundations Expand Philanthropic Efforts
      Coatings World

      Latest Breaking News From Coatings World

      PPG Hosts The Future of Coatings' Technology Innovation Day in Amsterdam
      Azelis Expands Presence in India with Acquisition of Chemo India and Unipharm Laboratories
      Teknos Publishes Sustainability Report
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      Pediatric Medical Device Competition Reveals Five Finalists
      Medical Device Packaging Market to Reach $34B by 2027
      Penumbra Secures CE Mark for its Advanced Mechanical Thrombectomy Tech
      Contract Pharma

      Latest Breaking News From Contract Pharma

      Mirum Pharmaceuticals Acquires San Diego-based Satiogen
      Catalyst Biosciences Sells Complement Portfolio to Vertex Pharmaceuticals
      Insmed Appoints Drayton Wise as Chief Commercial Officer
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      La Roche-Posay Launches Matte Moisturizer for Oily Skin
      3 Amorepacific Employees Stole $2.3 Million
      L'Oreal CEO Nicolas Hieronimus On Sustainability Initiatives
      Happi

      Latest Breaking News From Happi

      L’Oréal's New UVMune 400 Sun Filtering Technology Protects Skin From Ultra-Long UVA Rays
      TikToker Abbie Herbert, Founder of Personal Care Brand Pavot, Launches Body Water, Razor Burn Treatment Pads With Beaubble Partnership
      E.l.f. Cosmetics Introduces ‘Big Mood Pride Mascara’ Ahead of Pride Month
      Ink World

      Latest Breaking News From Ink World

      Epson Introduces Two New SurePress Digital Label Presses
      Flint Group Flexible Packaging Europe Implements Further Price Increase
      Nazdar Launches 205 Series Inks for Roland TrueVIS SG2 and VG2 Series Printers
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      AWA to host 22nd Global Release Liner Industry Conference & Exhibition
      Domino assists Grace Label with supply chain disruptions
      Rotocon wins AI Business Excellence Award
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      Rael Raises $35M in Series B Funding
      Schobertechnologies Offers Rotary Web-fed Converting Solutions
      Thorne Relaunches Gut Health Test with Microbiome Wipe
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      Emovi, Geneva Foundation Providing Knee Treatment Tech to U.S. Army
      Study Confirms Knee Shapes are Highly Individualized
      Stryker Launches EasyFuse Dynamic Compression for Foot & Ankle
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      InnovationLab Acquires Flexible Printed Battery Technology from Evonik
      Canatu Receives IATF 16949:2016 Certification
      Applied Materials Announces 2Q 2022 Results

      Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login